Correlation Analysis of Peripheral Blood SAA/CRP and NLR Levels with HBV-DNA Lload and Degree of Disease in CHB Patients

Chunyan CHEN; Zimian FAN

doi:10.12259/j.issn.2095-610X.S20240522

Volume 45 Issue 5

May 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(5): 144-150

Chunyan CHEN, Zimian FAN. Correlation Analysis of Peripheral Blood SAA/CRP and NLR Levels with HBV-DNA Lload and Degree of Disease in CHB Patients[J]. Journal of Kunming Medical University, 2024, 45(5): 144-150. doi: 10.12259/j.issn.2095-610X.S20240522

Citation:

Chunyan CHEN, Zimian FAN. Correlation Analysis of Peripheral Blood SAA/CRP and NLR Levels with HBV-DNA Lload and Degree of Disease in CHB Patients[J]. Journal of Kunming Medical University, 2024, 45(5): 144-150. doi: 10.12259/j.issn.2095-610X.S20240522

Citation:

PDF( 723 KB)

Correlation Analysis of Peripheral Blood SAA/CRP and NLR Levels with HBV-DNA Lload and Degree of Disease in CHB Patients

doi: 10.12259/j.issn.2095-610X.S20240522

Chunyan CHEN¹,
Zimian FAN²

1.
Dept.of Clinical Laboratory，Dazhou Hospital of Integrated Traditional Chinese and Western Medicine，Dazhou Sichuan 635000
2.
Dept. of Clinical Laboratory，The 6th People’s Hospital of Chengdu，Chengdu Sichuan 610000，China

Received Date: 2024-01-12
Available Online: 2024-04-29
Publish Date: 2024-05-31

Abstract

Abstract

Objective To investigate the correlation and clinical significance of peripheral blood serum amyloid A （SAA） to C-reactive protein （CRP） ratio （SAA/CRP）, neutrophils lymphocytes ratio （NLR） and HBV-DNA levels and disease severity in patients with chronic hepatitis B （CHB）, so as to find out the correlation between SAA and CRP （SAA/CRP）, neutrophils lymphocytes ratio （NLR） and hepatitis B virus-deoxyribonucleic acid （HBV-DNA）. Methods From June 2020 to June 2022, 100 patients with CHB in our hospital were selected as the study subject and were divided into the mild group （simple CHB, 36 cases）, the moderate group （cirrhosis in the compensated stage of hepatitis B, 33 cases） and the severe group （cirrhosis in the decompensated stage of hepatitis B, 31 cases） according to the degree of disease. And at the same time, another 50 healthy volunteers with the same age were selected as the control group. Different disease degrees, general information, serum SAA/CRP and NLR levels in the control group, and serum SAA/CRP and NLR levels in patients with different HBV-DNA loads in the study group were compared respectivly and the correlation between the serum SAA/CRP and NLR levels in patients with CHB and HBV-DNA loads and disease degrees were analyzed. The correlation between the serum SAA/CRP, NLR levels and HBV-DNA load and the degree of disease in CHB patients was analyzed. All patients were treated with the antiviral therapy for 24 weeks, and serum SAA/CRP, NLR levels and the change values of patients with different antiviral efficacies were compared before the treatment and 12 weeks and 24 weeks after the treatment and the value of the change values of serum SAA/CRP, NLR levels before and after the treatment was analyzed so as to predict the efficacy of the therapy. Results Serum SAA/CRP and NLR levels in severe patients > moderate patients > mild patients > control group （P < 0.05）; serum SAA/CRP and NLR levels in high carrier patients > moderate carrier patients > mild carrier patients （P < 0.05）; serum SAA/CRP and NLR levels in CHB patients were positively correlated with HBV-DNA load （r = 0.756, 0.709） , and disease extent （r = 0.776, 0.745） were positively correlated （P < 0.05）;The levels of peripheral blood SAA/CRP and NLR at 12 and 24 weeks after the treatment were higher in non-responders than in responders, and the change values were lower than in responders （P < 0.05）; the AUCs predicted by SAA/CRP∆1 and NLR∆1 alone were 0.752, 0.773 for SAA/CRP△1 and NLR△1 alone, and 0.861 for combined prediction of △1; the AUCs for SAA/CRP△2 and NLR△2 alone were 0.796 and 0.819, respectively, and 0.967 for combined prediction of △2, which were greater than those for combined prediction of △1 （P < 0.05）. Conclusion SAA/CRP and NLR are significantly correlated with HBV-DNA load and disease extent in CHB, and the changes in their levels can be used clinically to assess the disease and predict the prognosis, so as to target the follow-up treatment and improve the prognosis.
- Chronic hepatitis B,
- Hepatitis B virus-deoxyribonucleic acid,
- Peripheral blood amyloid A,
- C-reactive protein,
- Neutrophils,
- Lymphocytes

FullText(HTML)

References(29)

References

[1]	Inoue T,Tanaka Y. Novel biomarkers for the management of chronic hepatitis B[J]. Clin Mol Hepatol,2020,26(3):261-279. doi: 10.3350/cmh.2020.0032
[2]	Wang W,Zhou X,Bian Y,et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B[J]. Nat Nanotechnol,2020,15(5):406-416. doi: 10.1038/s41565-020-0648-y
[3]	Genshaft A S,Subudhi S,Keo A,et al. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients[J]. Hepatology,2023,78(5):1525-1541.
[4]	Ye B,Ding Q,He X,et al. High C-reactive protein-to-lymphocyte ratio is predictive of unfavorable prognosis in HBV-associated decompensated cirrhosis[J]. Lab Med,2022,53(6):149-153.
[5]	Pope J E,Choy E H. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities[J]. Semin Arthritis Rheum,2021,51(1):219-229. doi: 10.1016/j.semarthrit.2020.11.005
[6]	Zahorec R. Neutrophil-to-lymphocyte ratio,past,present and future perspectives[J]. Bratisl Lek Listy,2021,122(7):474-488.
[7]	Kosekli M A. Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis[J]. Eur J Gastroenterol Hepatol,2022,34(3):324-327. doi: 10.1097/MEG.0000000000002219
[8]	中华医学会肝病学分会、中华医学会感染病学分会. 慢性乙型肝炎防治指南[J]. 中华内科杂志,2006,45(2):162-170.
[9]	Vachon A,Osiowy C. Novel biomarkers of hepatitis B virus and their use in chronic hepatitis B patient management[J]. Viruses,2021,13(6):951. doi: 10.3390/v13060951
[10]	张诗琬,陈星,刘娇,等. 慢性乙型肝炎患者停用核苷(酸)类似物后循环血清中HBV pgRNA、HBcrAg表达水平与复发的相关性分析[J]. 临床肝胆病杂志,2023,39(1):56-62.
[11]	Hirode G,Choi H S J,Chen C H,et al. Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis b: An international,multicenter,multiethnic cohort (retract-b study)[J]. Gastroenterology,2022,162(3):757-771. doi: 10.1053/j.gastro.2021.11.002
[12]	Kawanaka M,Nishino K,Kawamoto H,et al. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases[J]. World J Gastroenterol,2021,27(43):7497-7508. doi: 10.3748/wjg.v27.i43.7497
[13]	Airewele N E,Shiffman M L. Chronic hepatitis b virus in patients with chronic hepatitis c virus[J]. Clin Liver Dis,2021,25(4):817-829. doi: 10.1016/j.cld.2021.06.008
[14]	Tan M,Bhadoria A S,Cui F,et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol,2021,6(2):106-119. doi: 10.1016/S2468-1253(20)30307-1
[15]	易爱芬,高明. 不同Child-Pugh分级的慢性乙型肝炎合并肝硬化患者糖代谢和胰岛素分泌情况及与炎症反应相关性研究[J]. 黑龙江医学,2023,47(6):663-665.
[16]	Carbone T,Pafundi V,Schievano C,et al. Serum amyloid a in healthy subjects: Assessment of reference value using elisa method[J]. J Immunoassay Immunochem,2021,42(2):129-137. doi: 10.1080/15321819.2020.1837160
[17]	Lai Y,Li Y,Gao L. Serum amyloid a protein in cancer prognosis: A meta-analysis and systematic review[J]. Transl Cancer Res,2021,10(5):2255-2264. doi: 10.21037/tcr-20-3417
[18]	郭平,庄丽花,陈骊婷,等. 平均红细胞体积、红细胞分布宽度和血清淀粉样蛋白A监测慢性乙型肝炎进展的价值初探[J]. 检验医学,2020,35(11):1153-1157.
[19]	Guo X,Zhang W,Du J,et al. Acute-phase serum amyloid a may predict microvascular invasion and early tumor recurrence in patients with hepatitis b virus-related hepatocellular carcinoma undergoing liver resection[J]. J Invest Surg,2022,35(6):1368-1376. doi: 10.1080/08941939.2022.2035858
[20]	张素梅,景富春,姜晓倩,等. 血清PCT、SAA及IL-6联合检测对肝硬化腹水合并腹腔感染的诊断和预后评估价值[J]. 临床误诊误治,2021,34(12):45-48,63.
[21]	苏娟,石岳飞,张惠林. 肝硬化并肺部感染患者血清PCT、CRP、WBC的表达水平及临床意义[J]. 贵州医药,2022,46(1):29-30.
[22]	Wang Y,Liu Y,Liao H,et al. Serum hbv dna plus rna reflecting cccdna level before and during nas treatment in hbeag positive chb patients[J]. Int J Med Sci,2022,19(5):858-866. doi: 10.7150/ijms.71737
[23]	刘勇波,陈宗波,陈燕如,等. HBeAg阴性慢性乙型肝炎患者血清中TGF-β1、MAO、透明质酸水平与HBV-DNA载量的相关性分析[J]. 国际医药卫生导报,2021,27(19):3033-3037.
[24]	Takeuchi M,Vidigal P T,Guerra M T,et al. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis[J]. Gut,2021,70(2):342-356.
[25]	Essa S,Siddique I,Saad M,et al. Modulation of production of th1/th2 cytokines in peripheral blood mononuclear cells and neutrophils by hepatitis c virus infection in chronically infected patients[J]. Pathogens,2021,10(11):1519. doi: 10.3390/pathogens10111519
[26]	Cho Y,Szabo G. Two faces of neutrophils in liver disease development and progression[J]. Hepatology,2021,74(1):503-512. doi: 10.1002/hep.31680
[27]	祝欣雯,王卫兵,袁福兵,等. NLR联合血清IL-6水平预测慢加急性乙型肝炎肝衰竭患者近期预后的价值探讨[J]. 实用肝脏病杂志,2023,26(1):67-70.
[28]	Yu J I,Park H C,Yoo G S,et al. Clinical importance of the absolute count of neutrophils,lymphocytes,monocytes,and platelets in newly diagnosed hepatocellular carcinoma[J]. Sci Rep,2021,11(1):2614. doi: 10.1038/s41598-021-82177-5
[29]	吴玲,胡长青,刘贞君,等. 外周血NLR联合终末期肝病模型预测乙型肝炎相关慢加急性肝衰竭短期预后价值[J]. 中西医结合肝病杂志,2022,32(6):540-542,552.

Relative Articles(20)

Relative Articles

[1]	Rui YIN, Guowei MA, Wenxi YUE, Haixia GU, Ying ZHOU, Jie CHEN. Efficacy of Nucleotide Analog Monotherapy and Combination Therapy with Interferon in Treating Chronic Hepatitis B. Journal of Kunming Medical University, 2024, 46(): 1-10.
[2]	Tuan LI, Yu’e ZHOU, Li MA, Gui LIAO. Clinical Significance of C Reactive Protein and Procalcitonin Detection in Neonatal ABO Hemolytic Jaundice. Journal of Kunming Medical University, 2023, 44(1): 80-84. doi: 10.12259/j.issn.2095-610X.S20230122
[3]	Fan CAO, Yang-wen LIU, Lei WEI, Nan XIE, Yi-jian YANG, Cheng QIAN, Chun-mang LI, Bi-mang FU, Jiang-pin XU, Rong-ji YAN, Wang ZENG. Correlation between Hepatitis B Virus and Microvascular Invasion in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2021, 42(3): 127-134. doi: 10.12259/j.issn.2095-610X.S20210331
[4]	Zhi-rong ZHAO, Hai-wen LI, Ni-hong LU, Ling SHEN, Xiao-fei LI, Yong-rui YANG. A Clinical Study on the Use of Propofol Tenofovir in the Treatment of Chronic Hepatitis B. Journal of Kunming Medical University, 2021, 42(1): 89-93. doi: 10.12259/j.issn.2095-610X.S20210141
[5]	Li-xian YUAN, Hong-tao ZHANG, Rui LI, Kun-rui CHEN, Kun-qian CHEN, An-shu XU. Diagnostic Efficacy of Serum PIVKA-Ⅱ Detection in Primary Hepatocellular Carcinoma. Journal of Kunming Medical University, 2020, 41(12): 80-84. doi: 10.12259/j.issn.2095-610X.S20201223
[6]	Hong-bo CHEN, Li-ping CHEN, Yong-ming JIN, Li-na WANG, Li-rui ZHU, Rong-qiong SHEN. Comparative Study of Neutrophil Elastase and Total Antioxidant Capacity in Serum of COPD Patients with Different HRCT Phenotypes. Journal of Kunming Medical University, 2020, 41(12): 108-111. doi: 10.12259/j.issn.2095-610X.S20201229
[7]	Qi Xiao , Zhong Zhao Ming , Sun Chuan Zheng . . Journal of Kunming Medical University, 2020, 41(05): 140-144.
[8]	Xie Wei , Zhao Chuan , Wang Rong , Wang Wen Ping , Tu Hong . . Journal of Kunming Medical University, 2020, 41(02): 82-86.
[9]	Dai Bai Zhang , Ren Chao Feng , Zheng Qin Ling , Yang Yan Xia , Li Mei Hua . Changes in Composition of Lymphocytes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Kunming Medical University, 2017, 38(06): 64-67.
[10]	Teng Yan . Effect of Hemoperfusion on Inflammation Factors in Patients with Sepsis. Journal of Kunming Medical University,
[11]	Xie Shu 姮. Changes and Mechanisms of Immunodepression after Ischemic Stroke in Mice. Journal of Kunming Medical University,
[12]	He Feng Die . The Changes of Serum CRP， IL-2， MCP-1 and Hemorheology of Patients with Pelvic Inflammatory Disease. Journal of Kunming Medical University,
[13]	Du Hai Lian . . Journal of Kunming Medical University,
[14]	Ning Lin . . Journal of Kunming Medical University,
[15]	Niu Ling . . Journal of Kunming Medical University,
[16]	Su Ying . . Journal of Kunming Medical University,
[17]	Ren Shao Hai . . Journal of Kunming Medical University,
[18]	Cao Jia . Hp Infection and HLA-DR Antigen Expression in Peripheral Blood Lymphocytes and Monocytes among Family Members of Children with Recurrent Abdominal Pain. Journal of Kunming Medical University,
[19]	Qiu Hong Mei . . Journal of Kunming Medical University,
[20]	Zhang Xiao Chao . . Journal of Kunming Medical University,